These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience]. Bosković V; Glisić A; Petković S Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378 [TBL] [Abstract][Full Text] [Related]
44. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer. Yamakawa Y; Fujimura M; Hidaka T; Hori S; Saito S Gynecol Oncol; 2000 May; 77(2):264-70. PubMed ID: 10785476 [TBL] [Abstract][Full Text] [Related]
45. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655 [TBL] [Abstract][Full Text] [Related]
46. Neoadjuvant chemotherapy before surgery in cervical cancer. Eddy GL J Natl Cancer Inst Monogr; 1996; (21):93-9. PubMed ID: 9023836 [TBL] [Abstract][Full Text] [Related]
47. Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma. Zanetta G; Lissoni A; Gabriele A; Landoni F; Colombo A; Perego P; Mangioni C Gynecol Oncol; 1997 Mar; 64(3):431-5. PubMed ID: 9062145 [TBL] [Abstract][Full Text] [Related]
48. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Lupi G; Raspagliesi F; Zucali R; Fontanelli R; Paladini D; Kenda R; di Re F Cancer; 1996 Apr; 77(8):1472-8. PubMed ID: 8608531 [TBL] [Abstract][Full Text] [Related]
49. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors. Yeh SA; Wan Leung S; Wang CJ; Chen HC Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023 [TBL] [Abstract][Full Text] [Related]
50. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report. Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990 [TBL] [Abstract][Full Text] [Related]
51. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy]. Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176 [TBL] [Abstract][Full Text] [Related]
52. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Morris M; Eifel PJ; Burke TW; McNamara MM; Levenback C; Kavanagh JJ; Gershenson DM Gynecol Oncol; 1995 Apr; 57(1):72-8. PubMed ID: 7705704 [TBL] [Abstract][Full Text] [Related]
53. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer. Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935 [TBL] [Abstract][Full Text] [Related]
54. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer. Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150 [TBL] [Abstract][Full Text] [Related]
55. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Burke TW; Hoskins WJ; Heller PB; Shen MC; Weiser EB; Park RC Obstet Gynecol; 1987 Mar; 69(3 Pt 1):382-5. PubMed ID: 3822285 [TBL] [Abstract][Full Text] [Related]
56. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients. Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358 [TBL] [Abstract][Full Text] [Related]
57. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer. Kim HS; Kim JY; Park NH; Kim K; Chung HH; Kim YB; Kim JW; Kim HJ; Song YS; Kang SB Gynecol Oncol; 2010 Nov; 119(2):217-24. PubMed ID: 20705335 [TBL] [Abstract][Full Text] [Related]
58. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors. Tuipae S; Yanaranop M; Oniem N J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897 [TBL] [Abstract][Full Text] [Related]
59. Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy. Hosaka M; Watari H; Kato T; Odagiri T; Konno Y; Endo D; Mitamura T; Kikawa S; Suzuki Y; Sakuragi N J Surg Oncol; 2012 May; 105(6):612-6. PubMed ID: 22065519 [TBL] [Abstract][Full Text] [Related]
60. [Results of treatment of 177 stage Ib and IIa cervix cancers at the Zurich University Gynecologic Clinic]. Hammer F; Schreiner WE Gynakol Rundsch; 1989; 29(2):78-92. PubMed ID: 2737539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]